147 related articles for article (PubMed ID: 33233828)
1. The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism.
Bessey A; Chilcott J; Pandor A; Paisley S
Int J Neonatal Screen; 2020 Nov; 6(4):. PubMed ID: 33233828
[TBL] [Abstract][Full Text] [Related]
2. The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa Dehydrogenase Deficiency (Lchadd).
Bessey A; Chilcott J; Pandor A; Paisley S
Value Health; 2014 Nov; 17(7):A531. PubMed ID: 27201686
[No Abstract] [Full Text] [Related]
3. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases.
Moorthie S; Cameron L; Sagoo GS; Bonham JR; Burton H
J Inherit Metab Dis; 2014 Nov; 37(6):889-98. PubMed ID: 25022222
[TBL] [Abstract][Full Text] [Related]
4. A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK.
Bessey A; Chilcott J; Leaviss J; de la Cruz C; Wong R
Int J Neonatal Screen; 2019 Sep; 5(3):28. PubMed ID: 33072987
[TBL] [Abstract][Full Text] [Related]
5. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for inborn errors of metabolism: a systematic review.
Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
[TBL] [Abstract][Full Text] [Related]
7. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF
J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
[TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.
Bessey A; Chilcott JB; Leaviss J; Sutton A
Orphanet J Rare Dis; 2018 Oct; 13(1):179. PubMed ID: 30309370
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive cost-utility analysis of newborn screening strategies.
Carroll AE; Downs SM
Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
[TBL] [Abstract][Full Text] [Related]
12. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.
Autti-Rämö I; Mäkelä M; Sintonen H; Koskinen H; Laajalahti L; Halila R; Kääriäinen H; Lapatto R; Näntö-Salonen K; Pulkki K; Renlund M; Salo M; Tyni T
Acta Paediatr; 2005 Aug; 94(8):1126-36. PubMed ID: 16188860
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
[TBL] [Abstract][Full Text] [Related]
14. [The advisory report 'Neonatal screening' from the Health Council of The Netherlands].
Bolhuis PA; Page-Christiaens GC
Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2857-60. PubMed ID: 16398167
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
16. Detection of inborn errors of metabolism using GC-MS: over 3 years of experience in southern China.
Jiang M; Liu L; Mei H; Li X; Cheng J; Cai Y
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):375-80. PubMed ID: 25781538
[TBL] [Abstract][Full Text] [Related]
17. Breastfeeding experience in inborn errors of metabolism other than phenylketonuria.
Huner G; Baykal T; Demir F; Demirkol M
J Inherit Metab Dis; 2005; 28(4):457-65. PubMed ID: 15902548
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
